World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
25972
World Ranking
11019
National Ranking
5670

Sunil Krishnan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sunil Krishnan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 437 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sunil Krishnan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sunil Krishnan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sunil Krishnan is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple disciplines including Engineering, Health Professions, and Medicine, with specific emphasis on Biomedical Engineering, Organic Chemistry, Emergency Medical Services, Geriatrics and Gerontology, and Health Information Management.

Their recent publications cover a range of topics primarily centered on advanced sensor technology, patient safety, and gene therapy. These include works such as:

  • Advances in real-time water quality monitoring using triboelectric nanosensors, 2025, Journal of Materials Chemistry A
  • Connecting the Dots: Communication's Role in Reducing Medication Errors - A Systematic Review, 2025, Sarvodaya International Journal of Medicine
  • 169 First-in-human safety and mechanism of action (MOA) analyses of repeatedly dosed in vivo gene delivery for directed human type III collagen (COL3) expression in aesthetics, 2021, Journal of Investigative Dermatology

Their work addresses topics including Advanced Sensor and Energy Harvesting Materials, Advanced Chemical Sensor Technologies, Polydiacetylene-based materials and applications, Patient Safety and Medication Errors, Pharmaceutical Practices and Patient Outcomes, Electronic Health Records Systems, and Virus-based gene therapy research.

The most frequent publication venues for their work are:

  • Journal of Materials Chemistry A
  • Sarvodaya International Journal of Medicine
  • Journal of Investigative Dermatology

Sunil Krishnan has collaborated with several co-authors, including Adewale Giwa, B. Ramesh, Pooja Singh, N. Angeloff, and N. Reitze, reflecting a multidisciplinary approach spanning materials science, medical research, and clinical communication.

Best Publications

  • Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-κB–Regulated Gene Products

    Ajaikumar B. Kunnumakkara;Sushovan Guha;Sunil Krishnan;Parmeswaran Diagaradjane

  • PDL1 Regulation by p53 via miR-34

    Maria Angelica Abdalla Cortez;Cristina Ivan;David Valdecanas;Xiaohong Wang

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

    Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun

  • Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

    In Ja Park;Y. Nancy You;Atin Agarwal;John M. Skibber

  • Nanoparticle-mediated hyperthermia in cancer therapy

    Dev Kumar Chatterjee;Parmeswaran Diagaradjane;Sunil Krishnan

  • Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

    Michael B. Bernstein;Sunil Krishnan;James W. Hodge;Joe Y. Chang

  • Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

    Prajnan Das;John M. Skibber;Miguel A. Rodriguez-Bigas;Barry W. Feig

  • Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

    Christopher H. Crane;Gauri R. Varadhachary;John S. Yordy;Gregg A. Staerkel

  • Biliary cancer: Utility of next-generation sequencing for clinical management.

    Milind Javle;Tanios Bekaii-Saab;Apurva Jain;Ying Wang

  • Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

    Sunil Krishnan;Vishal Rana;Nora A. Janjan;Gauri R. Varadhachary

  • Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation

    Sunil Krishnan;Awalpreet S. Chadha;Yelin Suh;Hsiang Chun Chen

  • Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

    Chad Tang;Xiaohong Wang;Hendrick Soh;Steven Seyedin

  • Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

    Paul D. Brown;Sunil Krishnan;Jann N. Sarkaria;Wenting Wu

  • The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources

    Sang Hyun Cho;Bernard L Jones;Sunil Krishnan

  • Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy.

    Parmeswaran Diagaradjane;Anil Shetty;James C. Wang;Andrew M. Elliott

  • Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis

    Randa Tao;Sunil Krishnan;Priya R. Bhosale;Milind M. Javle

  • Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls

    Jihyoun Lee;Jihyoun Lee;Dev Kumar Chatterjee;Min Hyuk Lee;Sunil Krishnan

  • Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations

    Bernard L. Jones;Sunil Krishnan;Sang Hyun Cho

  • Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer

    Kuzhuvelil B. Harikumar;Ajaikumar B. Kunnumakkara;Gautam Sethi;Parmeswaran Diagaradjane

Frequent Co-Authors

Christopher H. Crane
Christopher H. Crane Memorial Sloan Kettering Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Cathy Eng
Cathy Eng Vanderbilt University
John M. Skibber
John M. Skibber The University of Texas MD Anderson Cancer Center
George J. Chang
George J. Chang The University of Texas MD Anderson Cancer Center
Miguel A. Rodriguez-Bigas
Miguel A. Rodriguez-Bigas The University of Texas MD Anderson Cancer Center
Milind Javle
Milind Javle The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean following a traditional path. Online programs now offer greater flexibility and open doors to various roles in healthcare. For those interested in healthcare administration, best mha programs can help you develop critical management skills to lead hospitals or health systems.

Existing nurses looking to advance their training while balancing work can consider rn to bsn online no clinicals accredited options, which enable career growth without the need for additional on-site clinical experience.

Doctor of Nursing Practice (DNP) degrees have also become more accessible online. Students who need an accelerated path can look into the dnp programs online or pursue specialized 1 year dnp program online tracks.

Each of these online degree options is designed to fit busy lifestyles and fast-track your advancement in the healthcare industry. Explore the programs that align best with your career ambitions.

Best Scientists Citing Sunil Krishnan

Trending Scientists

Recently Published Articles